Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review

Martina D'Agostin1, Domenica Squillaci1, Marzia Lazzerini2

  • 1Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.

Insights

Probiotics are widely used in children despite safety concerns. This review found invasive infections linked to probiotics, particularly in infants, highlighting the need for further safety research.

Area of Science:

  • Microbiology
  • Pediatrics
  • Infectious Diseases

Background:

  • Probiotics are widely administered to children, perceived as safe, despite evidence of effectiveness only in specific conditions.
  • Emerging concerns highlight potential risks, including severe opportunistic infections, especially in pediatric populations.

Purpose of the Study:

  • To systematically review and summarize case reports of invasive infections associated with probiotic use in children.
  • To identify the types of probiotics implicated and the clinical characteristics of affected pediatric patients.

Main Methods:

  • A comprehensive literature search was conducted across three electronic databases.
  • Case reports detailing probiotic-derived invasive infections in pediatric patients were identified without language restrictions.
  • Data from 49 case reports published between 1995 and June 2021 were analyzed.

Main Results:

  • Infections were attributed to various probiotic species, including Lactobacillus (35%), Saccharomyces (29%), and Bifidobacterium (31%).
  • The majority of affected patients (80%) were under two years old, with sepsis being the most common diagnosis (69.4%).
  • Underlying conditions like prematurity (55%) and intravenous catheter use (51%) were frequent predisposing factors; 6% of children died.

Conclusions:

  • Probiotic use in children, despite its widespread nature, is associated with a risk of severe invasive infections.
  • Infants, particularly those with predisposing conditions, are most vulnerable.
  • Further research is crucial to determine the actual incidence of probiotic-associated systemic infections.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.8K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
33
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
749